2,378
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma

, ORCID Icon, , , & ORCID Icon
Pages 294-302 | Received 09 Mar 2021, Accepted 01 May 2021, Published online: 11 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Zhuo Zhang, Duoli Zhang, Fang Wang, Jiao Liu, Yuhong Sun, Songyot Anuchapreeda, Singkome Tima, Zhangang Xiao & Suwit Duangmano. (2023) Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway. PeerJ 11, pages e15172.
Crossref
Cecilia Bica, Alexandru Tirpe, Andreea Nutu, Cristina Ciocan, Sergiu Chira, Eugen S. Gurzau, Cornelia Braicu & Ioana Berindan-Neagoe. (2023) Emerging roles and mechanisms of semaphorins activity in cancer. Life Sciences 318, pages 121499.
Crossref
Zexu Lin, Xin Lin, Yuming Sun, Shaorong Lei, Gengming Cai & Zhexuan Li. (2023) Melanoma molecular subtyping and scoring model construction based on ligand-receptor pairs. Frontiers in Genetics 14.
Crossref
Satoshi Nojima. (2022) Class IV semaphorins in disease pathogenesis. Pathology International 72:10, pages 471-487.
Crossref
Ni Zeng, Qingyue Xia, Yueyue Li, Liwen Ma, Yuxin Cheng, Yihe Chen, Qian Lu, Zhiyu Lu, Di Wu & Dan Luo. (2022) Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma. Current Pharmaceutical Design 28:28, pages 2349-2361.
Crossref